Antimyosin antibodies in cardiac rejection

Annals of Thoracic Surgery

Volumn 63, Issue 2, 1997, Pages 578-581

  Schütz, Albert ^a   Breuer, Martin ^a   Kemkes, Bernhard M ^a  

^a KLINIKUM BOGENHAUSEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

MYOSIN ANTIBODY;

HEART MUSCLE CELL; HEART TRANSPLANTATION; HUMAN; MYOCARDITIS; PRIORITY JOURNAL; REVIEW; SCINTIGRAPHY;

ADULT; ANIMALS; AUTOANTIBODIES; CHILD; GRAFT REJECTION; HEART; HEART TRANSPLANTATION; HUMANS; INDIUM RADIOISOTOPES; MYOSINS;

EID: 0343990735     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0003-4975(96)01106-X     Document Type: Review

References (19)

1. Khaw BA, Mattis JA, Melincoff G. Monoclonal antibody to cardiac myosin: imaging of experimental myocardial infarction. Hybridoma 1984;3:11-23.
2. Khaw BA, Fallon JT, Beller GA, Haber E. Specificity of localization of myosin-specific antibody fragments in experimental myocardial infarction. Circulation 1979;60:1527-31.
3. Addonizio LJ, Michler RE, Marboe C, et al. Imaging of cardiac allograft rejection in dogs using indium-111 monoclonal antibodies Fab. J Am Coll Cardiol 1987;9:555-64.
4. Frist W, Yasuda T, Segall G, et al. Noninvasive detection of human cardiac transplant rejection with indium-111 antimyosin (Fab) imaging. Circulation 1987;76(Suppl 5):81-5.
5. Carrio I, Berna L, Ballester M, et al. Indium-111 antimyosin scintigraphy to assess myocardial damage in patients with suspected myocarditis and cardiac rejection. J Nucl Med 1988;29:1893-900.
6. Nardo D, Scibilia G, Macchiarelli A, et al. The role of indium-111 antimyosin (Fab) imaging as a noninvasive surveillance method of human transplant rejection. J Heart Transplant 1989;8:407-12.
7. Schütz A, Fritsch S, Kemkes BM, et al. Antimyosin monoclonal antibodies for early detection of cardiac allograft rejection. J Heart Transplant 1990;9:654-61.
8. Breuer M, Schütz A, Hammer C, Gansera B, Engelhart M, Kemkes BM. Scintigraphy and immunohistology of antimyosin-Fab during graft rejection. Vase Surg (in press).
9. Khaw B, Gold H, Yasuda T, et al. Scintigraphic quantification of myocardial necrosis in patients after intravenous injection of myosin-specific antibody. Circulation 1986;47:501-8.
10. Khaw BA, Beller GA, Haber E, Smith T. Localization of cardiac myosin-specific antibody in myocardial infarction. J Clin Invest 1976;58:439-46.
11. Billingham M. Some recent advances in cardiac pathology. Hum Pathol 1979;10:25-30.
12. Zerbe T, Arena V. Diagnostic reliability of endomyocardial biopsy for assessment of cardiac allograft rejection. Hum Pathol 1988;19:1307-14.
13. Henney C. Studies on the mechanism of lymphocyte-mediated cytolysis. II. The use of various target cell markers to study cytolytic events. J Immunol 1973;110:73-84.
14. Hall T, Baumgartner W, Borkon A, et al. Diagnosis of acute rejection with antimyosin monoclonal antibody, phosphorus nuclear magnetic resonance imaging, two-dimensional echocardiography and endomyocardial biopsy. J Heart Transplant 1986;5:419-24.
15. Nishimura T, Sada M, Saski H, et al. Identification of cardiac rejection in heterotopic heart transplantation using 111-In-antimyosin. Eur J Nucl Med 1987;13:343-7.
16. Kleinhans KJ. Die Myokardszintigraphie mit einem monoclonalen Myosin-Antikörper am Beispiel einer retrospektiven Auswertung klinischer Untersuchungen. Dissertation an der LMU. Munich, 1996.
17. Kemkes BM, Schütz A, Engelhardt M, Brandl U, Breuer M. Noninvasive methods of rejection diagnosis after heart transplantation. J Heart Transplant 1992;11:221-31.
18. Brandl U, Reichenspurner H, Schütz A, et al. Antimyosin scintigraphy after orthotopic heart transplantation in children. Transplant Proc 1994;26:205-6.
19. Antimyosin Fab-DTPA imaging agent for myocardial necrosis. License application for the manufacture of a monoclonal antibody product. Malvern, PA: Centocor, Inc, 1983.